Mr Chris Hall was appointed as a Non-Executive Director effective 30 September 2025.
Chris brings to the Board extensive experience across asset management, superannuation and, recently, biotechnology. His career has included roles as Chair, Non-Executive Director and Chief Investment Officer, along with senior executive positions in Australia and Hong Kong.
Chris’ current roles include Chair of BiomeBank, Non-Executive Director, Investment Committee Member and Audit Committee Member of AMP Superannuation, Non-Executive Director and Audit Committee Member of Funds SA, Investment Committee Chair of Perks Private Wealth, and Member of the Advisory Board to the Long-Term Value Fund at Tanarra Capital.
Chris holds a Bachelor of Business from the University of South Australia and he has completed the Professional Management Program (MBA Program) at the University of Adelaide. He is also a member of the Australian Institute of Company Directors.